Comment on: Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment: reply

Mickaekl Hiligsmann^*, Benedict G. Dellaert, Verity Watson, Annelies Boonen

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	584-585
Number of pages	2
Journal	Rheumatology
Volume	57
Issue number	3
DOIs	https://doi.org/10.1093/rheumatology/kex430
Publication status	Published - 1 Mar 2018

Access to Document

@article{2fe7f115d89746949e58334e4e05e927,

title = "Comment on: Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment: reply",

author = "Mickaekl Hiligsmann and Dellaert, {Benedict G.} and Verity Watson and Annelies Boonen",

year = "2018",

month = mar,

day = "1",

doi = "10.1093/rheumatology/kex430",

language = "English",

volume = "57",

pages = "584--585",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Comment on: Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment: reply

AU - Hiligsmann, Mickaekl

AU - Dellaert, Benedict G.

AU - Watson, Verity

AU - Boonen, Annelies

PY - 2018/3/1

Y1 - 2018/3/1

U2 - 10.1093/rheumatology/kex430

DO - 10.1093/rheumatology/kex430

M3 - Comment/Letter to the editor

C2 - 29194497

SN - 1462-0324

VL - 57

SP - 584

EP - 585

JO - Rheumatology

JF - Rheumatology

IS - 3

ER -